What are major issues for the 2nd year half in Korean drug market?
Korea must be careful regarding exporting pharmaceutical products this year due to various aspects such as nullification of the Ecuadorian drug agreement and Indonesian ‘Protectionism.’
The KOTRA(Korea Trade-Investment Promotion Agency) analyzed and introduced the ‘Korea Import Control for 2018 ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.